Hevert-Arzneimittel

What Hevert-Arzneimittel does

Hevert-Arzneimittel GmbH & Co. KG is a privately held, third-generation family-owned German pharmaceutical manufacturer founded in 1956 in Sobernheim and now headquartered in Nussbaum near Bad Sobernheim. The company produces over 100 homeopathic complex remedies, herbal/phytotherapeutic preparations rooted in traditional Felke formulas, and high-dose micronutrient supplements (e.g., Vitamin D3 Hevert in 1000 IU and 4000 IU dosages) in tablet, drop, capsule, and injectable forms, with more than 95% of medicines manufactured in-house at GMP-certified facilities that include modern cleanrooms, a dedicated quality control laboratory, and own medicinal plant cultivation. Roughly 30 fresh plant species are processed annually into mother tinctures, supplying the vertically integrated production chain.

The company serves three primary customer segments through a hybrid go-to-market motion: German end consumers purchasing natural remedies via retail and mail-order pharmacies for self-medication; naturopathic practitioners and pharmacies reached through a dedicated field sales force and the Hevert-Akademie continuing education program; and international export markets including Belarus, Mongolia, China, Luxembourg, Austria, Ukraine, the UAE, the USA, India, and Colombia, served via local distributors under a Made-in-Germany quality promise. Hevert monetizes through one-time product sales of pharmaceutical preparations; pricing is not publicly disclosed and products are dispensed through professional pharmacy channels rather than direct e-commerce.

Hevert is led by Managing Directors Mathias Hevert and Marcus Hevert, with sister Sarah Hevert as a shareholder of family holding HG Holding GbR. The company operates from Nussbaum headquarters plus a Berlin liaison office opened in 2017, maintains climate-neutral certification since 2022, and pursues advocacy and research partnerships through ECHAMP, Witten/Herdecke University, the Homeopathy Research Institute, and other European integrative medicine bodies. The product portfolio is complemented by three mobile applications (Calmvalera, Vademecum, Hevert Akademie) that extend engagement and education for practitioners and consumers.

Name

Hevert-Arzneimittel

Legal name

Hevert-Arzneimittel GmbH & Co. KG

Website

https://hevert.com

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

51–100 employees

Short description

Hevert-Arzneimittel is a third-generation, family-owned German manufacturer of homeopathic complex remedies, herbal medicines, and high-dose micronutrient supplements, producing over 100 preparations in-house and serving pharmacies, naturopathic practitioners, and consumers in Germany plus ten export markets.

Ownership category

akta.pro rank

Product category

Homeopathic and Herbal Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Sleep, Stress & Mood Support (HLAIADAG)

akta.pro secondary industries

Cold, Flu & Cough Remedies (HLAIADAB), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC)

Keywords

• Homeopathic medicines
• Herbal medicines
• Micronutrient supplements
• Phytopharmaceutical preparations
• Natural pharmacy products

Headquarters

HQ city

Nußbaum

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Preparations Sales: Revenue generated from sale of homeopathic, herbal, and micronutrient preparations to pharmacies, practitioners, and directly to consumers across domestic and international markets.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Hevert-Arzneimittel manufactures and sells over 100 preparations of homeopathic complex remedies, phytotherapeutic (herbal) medicines, and high-dose micronutrient (vitamin and mineral) products for natural, low-side-effect treatment of conditions such as sleep disorders, colds and sinusitis, women's and children's health, and vitamin deficiencies. Products are offered in tablets, drops, capsules, and injectable (ampoule) dosage forms, with more than 95 percent manufactured in-house at GMP-compliant facilities in Nussbaum and Bad Sobernheim, Germany, and sold through pharmacies, mail-order pharmacies, and international distribution partners.

Product overview

Hevert-Arzneimittel is a German manufacturer of natural medicines offering over 100 preparations in tablet, drop, capsule, and injectable (ampoule) forms. The product portfolio consists of three core categories: homeopathic complex remedies and single remedies, herbal/ phytotherapeutic medicines, and high-dose micronutrient preparations. Key products include Sinusitis Hevert (homeopathic remedy for colds and sinusitis), Calmvalera Tabletten (herbal remedy for nervous disorders and sleep), and Vitamin D3 Hevert supplements in 1000 IU and 4000 IU dosages. The company operates its own manufacturing facilities at Bad Sobernheim and Nussbaum sites, with over 95% of medicines produced in-house. Hevert also offers three companion mobile applications: Calmvalera App for relaxation content, Vademecum App for product information, and Hevert Akademie App for training materials.

Differentiator

Problem solved

Functional benefit

Brands

• Calmvalera: Homeopathic preparation for nervous restlessness and sleep disorders, available as tablets.
• Sinusitis Hevert
• Hevert-Foundation

Products and services

• Homeopathic Medicines Broad range of homeopathic complex remedies and single remedies in tablet, drop, capsule, and injectable (ampoule) forms for therapeutic areas including psyche/sleep, colds, women's and children's health, and general wellness. Based on traditional Felke formulas refined over 65+ years.
• Herbal Medicines
• High-Dose Micronutrient Preparations
• Sinusitis Hevert
• Calmvalera Tabletten
• Vitamin D3 Hevert 4000 IU
• Vitamin D3 Hevert 1000 IU
• Calmvalera App
• Vademecum App
• Hevert Akademie App

Quantifiable outcome

• Relaxation verified within 90 minutes without detrimental effect on concentration (Calmvalera study)
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered minor and core.

• natureOfficeminorOthersClimate protection agency partnership for carbon footprint reporting and offset projects. Hevert sponsors climate protection projects in Togo, Kenya and Brazil through natureOffice to offset unavoidable carbon emissions.
• European Institute for Homeopathy (InHom)minorStrategic or Co-development PartnerHevert financially supported founding of this institute for homeopathy research and education.
• Homeopathy Foundation of the German Central Union of Homeopathic PhysiciansminorStrategic or Co-development PartnerFinancial involvement in foundation supporting homeopathic medicine development and research.
• Homeopathy Research Institute (London)minorStrategic or Co-development PartnerSupport for basic research into homeopathic preparations as part of academic foundation building for homeopathy and naturopathy.
• Witten/Herdecke UniversityminorStrategic or Co-development PartnerCooperative research projects supporting basic research into homeopathic preparations.
• ECHAMP (European Coalition on Homeopathic and Anthroposophic Medicinal Products)coreStrategic or Co-development PartnerHevert joined ECHAMP in 2005 to advocate for marketability of homeopathic and anthroposophic products at EU level. Mathias Hevert has been on the Board of Management since 2013.
• Stadtbienen (Urban Bees)minorOthersCharity maintaining bee population at Hevert's Berlin office location as part of environmental sustainability initiatives.
• NABU (Naturschutzbund Deutschland e.V.)minorOthersNature conservation organization supported by Hevert Foundation for preservation of native flora and fauna diversity.
• Hufeland-GesellschaftminorStrategic or Co-development PartnerLong-standing support for society promoting naturopathy and integrative medicine approaches.
• Kooperation PhytopharmakaminorStrategic or Co-development PartnerMembership in organization supporting phytopharmaceutical research and development.
• Association of Natural Medicines in Europe (ANME)minorStrategic or Co-development PartnerMembership in association for natural medicines at European level.

Scale indicators6 records

Recent moves10 records

Expansion highlights5 records

Direct peers

• Deutsche Homöopathie-Union (DHU): DHU is a German homeopathic medicine manufacturer (Karlsruhe) producing single remedies and complex preparations distributed primarily through pharmacies. The company directly competes with Hevert in the German pharmacy channel with overlapping homeopathic product lines and similar GMP manufacturing infrastructure.
• Biologische Heilmittel Heel GmbH: Heel is a German manufacturer of homeopathic combination medicines headquartered in Baden-Baden. As one of the leading homeopathic pharmaceutical companies globally with a comparable product portfolio covering colds, inflammation, and women's health, Heel is the closest direct competitor to Hevert in therapeutic scope and channel (pharmacy distribution).
• Pascoe pharmazeutische Präparate GmbH: Pascoe is a German family-owned manufacturer of homeopathic, phytotherapeutic, and micronutrient preparations. Comparable to Hevert in product categories (homeopathic complexes, herbal remedies, vitamin supplements), German pharmacy channel focus, and mid-market scale.
• Dr. Willmar Schwabe GmbH & Co. KG: Schwabe is a leading German manufacturer of phytopharmaceuticals and homeopathic medicines headquartered in Karlsruhe. Comparable to Hevert as a family-owned German natural-medicine producer with international distribution and a focus on clinically validated botanical preparations.
• Weleda AG: Weleda is a Swiss-German manufacturer of anthroposophic and homeopathic pharmaceuticals alongside natural cosmetics. While broader in scope (including personal care), its pharmaceutical division directly overlaps with Hevert's natural-medicine product portfolio and international pharmacy distribution model.
• WALA Heilmittel GmbH: WALA manufactures anthroposophic and homeopathic medicines in Bad Boll, Germany. Comparable to Hevert in being a German natural-medicine manufacturer with pharmacy distribution, in-house cultivation/production, and similar product portfolio breadth.
• Klosterfrau Melissengeist (Klosterfrau Vertriebsgesellschaft): Klosterfrau is a German manufacturer of traditional herbal medicinal products with strong pharmacy presence in Germany. Comparable to Hevert in herbal/natural-medicine category, German pharmacy distribution, and emphasis on traditional formulations passed down over decades.

Regional players

• Ceres Heilmittel AG: Ceres is a Swiss manufacturer of homeopathic spagyric medicines derived from medicinal plants. Comparable niche positioning in plant-based homeopathic preparations and natural pharmacy channel, but primarily serving Switzerland rather than Hevert's core German and broader international markets.
• Schwabe Pharma AG (Switzerland): Schwabe Pharma is the Swiss affiliate of the Schwabe group producing homeopathic and phytotherapeutic medicines for the Swiss market. Comparable to Hevert in product portfolio and manufacturing approach, but with primary focus on the Swiss German-speaking market rather than Germany.

Broad incumbents

• Bayer Consumer Health: Bayer's Consumer Health division sells OTC and natural health brands globally through pharmacy and retail channels. As a broad incumbent in the same end-markets (cold/cough, sleep, vitamins), Bayer competes with Hevert primarily through scale advantages in marketing and distribution, though it does not focus exclusively on homeopathy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hevert-Arzneimittel